Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected

J Infect. 2022 Apr;84(4):e31-e33. doi: 10.1016/j.jinf.2022.02.009. Epub 2022 Feb 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adaptation, Physiological
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • RNA, Messenger

Substances

  • COVID-19 Vaccines
  • RNA, Messenger